Remdesivir Priced At More Than $3,100 For A Course Of Treatment

Gilead Sciences, maker of the antiviral drug remdesivir, has come up with a price for the COVID-19 treatment that was less than some analysts expected.

An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.

(Image credit: ULRICH PERREY/POOL/AFP via Getty Images)



from News : NPR https://ift.tt/3g8T0w5
https://ift.tt/3dMxsnz

Comentarii

Trimiteți un comentariu

Postări populare de pe acest blog

Covid inquiry defended despite scrutiny

Politicians including the treasurer have defended the government’s inquiry into the COVID-19 pandemic response, insisting it is a worthwhile exercise despite widespread condemnation it has been excluded from scrutinising the unilateral decisions made by each state. from Latest News and News Headlines | Daily Telegraph https://ift.tt/tsL8jh6 https://ift.tt/YLZWxQz
Citiți mai multe